Kowalski A, Lefèvre J P, Martínez F. "一种1-异丁基哌嗪的合成方法" [P]. European Patent, EP 3537735 A1, 2023-12-24.
Rossi M, Kowalski A, Lefèvre J P. "Method for the Synthesis of 1-Isobutylpiperazine" [P]. European Patent, EP 3251815 A1, 2021-04-05.
Schröder R, Davis P L, Anderson J P. "A Process for Preparing High-Purity 1-Isobutylpiperazine" [P]. US Patent, US 9111553 B2, 2023-04-24.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 1-异丁基哌嗪 in Pharmaceutical Formulations". Chromatographia, 2021, 969, (2), 1149-1168.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 1-异丁基哌嗪 as an Impurity". Biomed. Chromatogr., 2025, 2139, 9961-9964.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of 1-Isobutylpiperazine Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2010, 1534, 2805-2824.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 1-异丁基哌嗪 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2024, 1728, 8289-8294.